• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

Atranorin Inhibitor

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS5760156

Atranorin shows significant antinociceptive and antiinflammatory activities, it has a relevant redox-active action, acting as a pro-oxidant or antioxidant agent depending on the radical, also, it will exert cytoprotective effects on cells under oxidative… More details

Product Documentation
PDF
Sample Manual Insert View PDF
PDF
Testing Data View PDF
PDF
Certificate of Analysis (COA) View PDF
PDF
QC Report View PDF
PDF
Material Safety Data Sheet View PDF
PDF
Technical Datasheet View PDF
PDF
Protocol View PDF

Product Overview

Online Datasheet in PDF
Product Name
Atranorin, Inhibitor
Full Product Name
Atranorin
Form/Format
Solid. Powder
Purity/Purification
98.00%
Preparation and Storage
Store at -20 degree C for 3 years powder
-80 degree C for 2 years in solvent
Molecular Weight
374.4
Solubility
<1mg/ml refers to the product slightly soluble or insoluble
Formula
C19H18O8
SMILES
Cc1cc(O)c(C=O)c(O)c1C(Oc1c(C)c(O)c(C(OC)=O)c(C)c1)=O
CAS Number
479-20-9
Target & IC50
NO Synthase
In Vitro
Three lichen secondary metabolites Atranorin (1), evernic acid (2), and usnic acid (3), were evaluated for their in vitro clastogenic and antiproliferative effects on human lymphocytes using the cytochalasin-B blocked micronucleus (CBMN) assay at concentrations of 2microg/mL, 4microg/mL and 6microg/mL of final culture solution. Atranorin at concentrations of 2microg/mL and 4microg/mL decreasing the frequency of MN only for 11.1% and 1.8%, while in concentration of 6microg/mL increases the frequency of MN for 9.6 %[1]

Product Categories/Family for Atranorin, inhibitor

Product References and Citations for Atranorin, inhibitor

Clastogenic effect of atranorin, evernic acid, and usnic acid on human lymphocytes.Nat Prod Commun. 2014 Apr;9(4):503-4.
Clastogenic effect of atranorin, evernic acid, and usnic acid on human lymphocytes.Nat Prod Commun. 2014 Apr;9(4):503-4.
Redox properties and cytoprotective actions of atranorin, a lichen secondary metabolite. Toxicol In Vitro. 2011 Mar;25(2):462-8.

Other Notes

Small volumes of Atranorin, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Searchable Terms for Atranorin purchase

MBS5760156 is an inhibitor targeting Atranorin.
Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000